Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CONTRAFECT CORPORATION

(CFRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ContraFect: Q1 Earnings Snapshot

05/14/2021 | 07:35am EDT

YONKERS, N.Y. (AP) _ ContraFect Corp. (CFRX) on Friday reported a loss of $5.2 million in its first quarter.

The Yonkers, New York-based company said it had a loss of 18 cents per share.

The company's shares closed at $3.58. A year ago, they were trading at $5.72.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CFRX at https://www.zacks.com/ap/CFRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about CONTRAFECT CORPORATION
05/26ContraFect Announces Multiple Publications on Exebacase, Including First Manu..
GL
05/21CONTRAFECT CORP  : Submission of Matters to a Vote of Security Holders (form 8-K..
AQ
05/14CONTRAFECT CORP  : Results of Operations and Financial Condition, Financial Stat..
AQ
05/14CONTRAFECT  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
05/14CONTRAFECT : Q1 Earnings Snapshot
AQ
05/14ContraFect Reports First Quarter 2021 Financial Results and Provides Business..
GL
05/03ContraFect Announces Issuance of Composition of Matter Patent for CF-370 by t..
GL
04/26CONTRAFECT  : Invited to Participate in the Cystic Fibrosis Target Product Profi..
AQ
04/15ContraFect Invited to Present at the Inaugural Anti-Infectives Drug Developme..
GL
04/01CONTRAFECT  : Mizuho Adjusts ContraFect's Price Target to $10 From $12, Maintain..
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -37,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,12x
Yield 2021 -
Capitalization 169 M 169 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 33
Free-Float 95,1%
Chart CONTRAFECT CORPORATION
Duration : Period :
ContraFect Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CONTRAFECT CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 15,90 $
Last Close Price 4,29 $
Spread / Highest target 436%
Spread / Average Target 271%
Spread / Lowest Target 133%
EPS Revisions
Managers and Directors
NameTitle
Roger J. Pomerantz Chairman, President & Chief Executive Officer
Michael Messinger Chief Financial Officer
Cara Cassino Chief Medical Officer & EVP-Research & Development
Sol J. Barer Lead Independent Director
Cary William Sucoff Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CONTRAFECT CORPORATION-15.05%169
MODERNA, INC.109.49%87 874
LONZA GROUP AG16.32%54 656
IQVIA HOLDINGS INC.35.87%46 658
CELLTRION, INC.-26.04%32 458
SEAGEN INC.-10.60%28 416